Stay updated on Inhaled Esketamine for Bipolar Depression Clinical Trial
Sign up to get notified when there's something new on the Inhaled Esketamine for Bipolar Depression Clinical Trial page.

Latest updates to the Inhaled Esketamine for Bipolar Depression Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page history shows minor UI/versioning updates: added Revision: v3.4.2 and removed Revision: v3.4.1 from the study record versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoChange DetectedAdded Revision: v3.4.1 to the history; the funding-lapse notice was removed and the earlier Revision: v3.4.0 entry was replaced.SummaryDifference0.9%

- Check22 days agoChange DetectedA site-wide notice about a lapse in government funding and operating status was added at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check29 days agoChange DetectedGlossary is now shown and additions/deletions are color-coded in the history view, with a revision note for v3.4.0.SummaryDifference1%

- Check36 days agoChange DetectedA new revision entry v3.3.4 was added to the record history, and the previous revision v3.3.3 was removed from the changes list.SummaryDifference0.1%

- Check65 days agoChange DetectedRecord History shows a new revision entry 'Revision: v3.3.3' added and the 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' entries removed. These are minor site maintenance updates and do not affect study data or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Inhaled Esketamine for Bipolar Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Esketamine for Bipolar Depression Clinical Trial page.